Novartis at ASCO

Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO)
May 27, 2020

We are boldly reimagining cancer and blood disorders.

Novartis 2020 ASCO Annual Meeting Virtual Portal

Four distinct therapeutic platforms – targeted therapies, cell and gene therapy, immunotherapy and radioligand therapy

 

Novartis is virtually present at ASCO

 

 

 

 

 


Press releases


Now is the time to accelerate progress in cancer care

COVID-19 is having a huge impact on cancer care. Susanne Schaffert, President of Novartis Oncology, reflects on the current situation and looks at what can be done in this LinkedIn article.

Read More


Additional resources

ASCO20 Homepage